

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.

Today, the International Energy Agency’s flagship report, the World Energy Outlook (WEO), reaffirms that world leaders must not develop new oil, gas, or coal beyond existing fields, and must close some existing fields and infrastructure early, to remain within the internationally agreed upon temperature limit. The WEO’s findings reinforce urgent calls for governments to commit to a fast, fair, funded, and full phase-out of fossil fuels at this year’s United Nations Climate Change Conference in Dubai (COP28).
The 2023 WEO highlights a significant gap between current energy policies and the immediate and rapid declines in oil, gas, and coal needed by 2030 to ensure a livable planet. In its current policies scenario (Stated Energy Policies Scenario, STEPS), the IEA finds that demand for oil and gas will peak by 2030 for the first time, and demand is predicted to grow between now and then. In contrast, in the Net Zero Emissions (NZE) scenario, the only WEO scenario aligned with limiting temperature rise to globally agreed limits, fossil fuel extraction and use must decrease by nearly 30% by 2030. The IEA emphasizes that while renewable energy can ramp up rapidly to meet global energy needs, governments must take more ambitious steps to swiftly and fairly transition away from fossil fuels.
The IEA has repeatedly confirmed that no new oil, gas, or coal fields are compatible with limiting global temperature rise to 1.5ºC, yet countries around the world continue to approve new fossil fuel fields and infrastructure. The WEO warns that today’s oil and gas investments are nearly double what is needed in the NZE scenario in 2030. Oil Change International’s latest research shows that even beyond stopping fossil fuel expansion, 60% of fossil fuels in existing fields must stay in the ground to limit global temperature rise to 1.5°C.
The WEO reinforces that some of the world’s wealthiest governments, key among them the United States, are driving new oil and gas extraction – despite having a clear responsibility to lead in phasing it out. For example, this year’s WEO documents that the U.S. is responsible for over 90% of gas export projects approved since the start of 2022, all of which are incompatible with the NZE scenario. Oil Change International’s recent Planet Wreckers report found the U.S. alone could be responsible for over one-third of carbon pollution caused by planned new oil and gas extraction through 2050. Oil Change International analysis also shows the U.S. has approved over $1.5 billion for six fossil fuel projects in 2023, breaking a key promise to end international public finance for fossil fuels.
Governments must put a stop to oil and gas expansion now to avoid locking in new carbon and methane pollution for decades into the future, and commit at COP28 to a fast, fair, and fully funded phase-out of fossil fuels.
Kelly Trout, Research Director, Oil Change International, said:
“What this year’s World Energy Outlook underscores is that the takeoff of renewable energy is keeping the path to a livable climate open, but it will close quickly unless governments commit to phase out fossil fuels now. We can’t solve the climate crisis by adding renewable energy on top of new fossil fuels – we need to rapidly replace and phase out all fossil fuels, including gas.
“There is a massive and deadly gap between current policies, which still lead to higher oil and gas use in 2030 than today, and the rapid declines in fossil fuels required to stave off runaway climate disaster. Every investment in new oil and gas infrastructure is an investment in more methane leaks, more warming, and more of the extreme heat, floods, fires, and drought destroying communities and ecosystems.
“The WEO has given a clear roadmap for the upcoming United Nations Climate Change COP28 negotiations: limiting warming to 1.5°C requires a clear decision on a fast, fair, and fully funded end of fossil fuels as well as a rapid deployment of renewable energy and energy efficiency, with wealthy countries in the lead and paying their fair share for a just energy transition. There is sufficient public money to do this. Governments must start by shifting their support from fossil fuels to the renewable and equitable future we need.”
Oil Change International is a research, communications, and advocacy organization focused on exposing the true costs of fossil fuels and facilitating the ongoing transition to clean energy.
(202) 518-9029"Trump has dressed up yet another corporate giveaway as a boon to patients," said one watchdog. "Real drug price reform doesn’t look like a website."
US President Donald Trump on Thursday launched a website, branded with his name, in a purported effort to help patients buy prescription drugs at lower prices.
But experts, watchdog groups, and Democratic lawmakers said TrumpRx will likely do little for consumers—or for the broader goal of bringing down exorbitant medicine costs—while further enriching Big Pharma and potentially lining the pockets of his eldest son, Donald Trump Jr.
TrumpRx.gov, launched in partnership with pharmaceutical giants, points users to direct-to-patient sales platforms hosted by drug companies to facilitate the purchase of an extremely limited selection of medications. For example, TrumpRx's listing for Farxiga links users to AstraZeneca Direct, where patients can pay out of pocket for the type 2 diabetes medication.
Donald Trump Jr. is on the board of BlinkRx, a prescription drug platform that stands to benefit from the Trump administration's promotion of direct-to-patient medicine sales. In December, the president's son reportedly met with top drug company executives and administration officials responsible for regulating the pharmaceutical industry—a gathering hosted by BlinkRx.
Frank Pallone Jr. (D-NJ), the top Democrat on the House Energy and Commerce Committee, said in a statement Thursday that TrumpRx "not only threatens patients’ health, safety, and privacy, but also likely includes kickback schemes designed to enrich President Trump, his family, and their friends."
"TrumpRx has been shrouded in secrecy from the beginning because the administration clearly does not want anyone to know it likely won’t save patients money," said Pallone. "However, we do know Trump only slaps his name on things when there’s something in it for him."
Last week, a group of Democratic senators sent a letter to the inspector general of the US Department of Health and Human Services warning that "without stricter safeguards before its official launch, TrumpRx could be used as a potential vehicle for unlawful kickback schemes that result in excessive costs for the federal government."
In addition to sending users to direct-to-patient sales sites, TrumpRx offers Trump-branded coupons for some medications. To obtain a coupon, site users must accept terms that state: "You agree that by redeeming this coupon, you (and anyone else acting on your behalf) agree not to seek reimbursement from any insurance plan for out-of-pocket costs for prescriptions purchased with this coupon. You also agree not to count the cost of prescriptions toward your deductible or true out-of-pocket costs."
The Washington Post reported that pharmaceutical companies "have agreed to list their drugs on TrumpRx.gov."
"TrumpRx is designed to help Big Pharma keep its prices high by diluting the bargaining power of insurance companies, weakening an important check on pharma."
Experts warned that patients who use TrumpRx could end up paying more for their medications than if they pursued other available options.
"TrumpRx’s offerings are very limited, fewer than 50 drugs listed, and most are niche products used by few patients," Rena Conti, an associate professor at Boston University, told ABC News. "Many are available in generic form at even lower prices or already available to consumers at low or even very low prices elsewhere. This suggests it pays for consumers to check their insurance coverage and ask their regular doctor or pharmacist before they use this service."
Peter Maybarduk, access to medicines director at Public Citizen, offered a more scathing assessment of TrumpRx, saying the president has "dressed up yet another corporate giveaway as a boon to patients."
"Most patients will do better through their insurance than through TrumpRx. Many patients without insurance will not be able to afford drugmakers’ still-high prices funneled through TrumpRx," said Maybarduk. "But drugmakers certainly will appreciate TrumpRx’s free promotion of their products, delivered with a false veneer of price accountability. TrumpRx is designed to help Big Pharma keep its prices high by diluting the bargaining power of insurance companies, weakening an important check on pharma."
“TrumpRx also appears to be another example of this president’s repeated corruption," he continued. "Trump’s son, Donald Trump Jr., sits on the board of BlinkRx, a key business that may benefit financially from TrumpRx. Getting serious about medicine affordability means getting serious about challenging Big Pharma. For all Trump’s talk, Big Pharma is getting a lot of special favors from this White House, while patients still are waiting. Real drug price reform doesn’t look like a website."
Throughout his second White House term, Trump has made outlandish promises to cut drug costs and hosted top executives at the White House to tout splashy deals—only for pharmaceutical giants to continue jacking up prices. Reuters reported last month that drugmakers planned to "raise US prices on at least 350 branded medications, including vaccines against Covid, RSV, and shingles and blockbuster cancer treatment Ibrance" in 2026.
Merith Basey, CEO of Patients for Affordable Drugs Now, said in a statement that the Trump administration's "voluntary agreements" with drug companies "lack clear enforcement mechanisms and still put the power to set and increase prices firmly in the hands of pharmaceutical corporations."
"Patients in our community will soon learn if they can reliably access these discounts at the pharmacy counter, where the program will ultimately be tested and where affordability matters most," Basey said of TrumpRx.
"The most foundational racist idea is likening Black people to apes," said Howard University historian Ibram X. Kendi.
President Donald Trump, a documented racist, drew swift condemnation on Friday night after he posted a video on his Truth Social account depicting former President Barack Obama and first lady Michelle Obama as monkeys.
As reported by The Guardian, the racist depiction of the Obamas was part of a longer video that featured "false and disproven claims that ballot-counting company Dominion Voting Systems helped steal the 2020 presidential election" from Trump.
The outrage over the post was immediate, even as Trump's racism is well known and documented over many years.
"The most foundational racist idea is likening Black people to apes," said Howard University historian Ibram X. Kendi in a social media post. "Since humans evolved from an ape-like ancestor, racist ideas cast white people as the most evolved people and the furthest away on the evolutionary scale from apes. Racist ideas cast Black people as the least evolved people and the closest on the evolutionary scale to apes. Almost all racist ideas build on this foundational one expressed by Trump."
A screenshot of the video Trump shared:

Tom Jocelyn, senior fellow at the Reiss Center on Law and Security, predicted how Trump and his allies would defend his promotion of obvious racism.
"Let’s call out a game Trump and MAGA play," he wrote. "1. Trump posts, says or does something racist. 2. Some point out it’s racist. 3. Trump (with MAGA’s help) pretends to be the victim for being called a racist. MAGA stews in its imaginary grievances. 4. Rinse and repeat."
Mark Jacob, former metro editor at the Chicago Tribune, called out the New York Times for writing that it was "unclear if Mr. Trump was aware" that the racist depiction of the Obamas "had been included in the video before he shared it."
"What the hell is the New York Times doing?" he asked. "In its article on Trump posting a video that included a clip of the Obamas as apes, NYT tries to help him come up with an excuse."
Ben Rhodes, former deputy national security adviser under Obama, argued that Trump's post was yet another sign that he will be remembered as a deeply loathsome historical figure.
"Let it haunt Trump and his racist followers that future Americans will embrace the Obamas as beloved figures," he wrote, "while studying him as a stain on our history."
"It is time for us to focus on what really matters: unrigging this economy, making sure we reclaim our democracy—and it starts right now," Mejia said as the race officially remained too close to call.
This is a developing story... Please check back for updates...
Progressive organizer Analilia Mejia emerged late Thursday as the leader of a crowded Democratic primary race for a vacant US House seat representing New Jersey's 11th Congressional District, potentially notching a stunning upset in a contest that saw outside groups—including one linked to AIPAC—spend millions.
The bulk of that money came from the United Democracy Project (UDP), a billionaire-funded pro-Israel group that spent big to defeat former Rep. Tom Malinowski (D-NJ) in favor of its preferred candidate, Tahesha Way. The investment appears to have backfired in embarrassing fashion: Way is currently sitting in a distant third place, while UDP's attacks on Malinowski—regarded as a pro-Israel Democrat during his time in Congress—appear to have harmed him enough to propel Mejia, who has called Israel's assault on Gaza a genocide.
While the primary race is officially too close to call, some analysts said they expect Mejia to win after the remaining ballots are counted. As of this writing, Mejia—whose campaign was backed by Sen. Bernie Sanders (I-Vt.), Rep. Alexandria Ocasio-Cortez (D-NY), and other prominent progressives—is holding to a 486-vote lead.
"New Jersey, I am so excited to say that we have delivered people-powered victory," Mejia, a supporter of Medicare for All and other progressive policy ambitions, said in a video posted to social media shortly after midnight. "It is time for us to focus on what really matters: unrigging this economy, making sure we reclaim our democracy—and it starts right now."
My message to New Jersey voters. pic.twitter.com/8u8EBy02f7
— Analilia Mejia for NJ (@AnaliliaForNJ) February 6, 2026
The New Jersey Working Families Party, which endorsed and supported Mejia, said in a statement that "while every vote must still be counted, Analilia Mejia’s performance is historic."
"Analilia shocked the New Jersey political establishment and did what so many people said she couldn’t,” said Antoinette Miles, the organization's state director. “Voters are hungry for working-class leaders, and tonight they showed it.”
Prominent outlets, including Decision Desk HQ, were forced to retract their earlier projections of a Malinowski win after the progressive candidate took the lead. Mejia rubbed it in by posting to X the famous photo of Harry Truman holding up a copy of the Chicago Daily Tribune that featured the erroneous banner headline, "Dewey Defeats Truman."
The winner of the 11th Congressional District primary and April 16 general election will fill the remainder of New Jersey Gov. Mikie Sherrill's congressional term, which expires in January 2027.
Progressives who backed Mejia's campaign attributed her late surge to persistent organizing and a last-ditch advertising push. Rep. Pramila Jayapal (D-Wash.) noted that while Mejia "was outspent by millions," strategic spending by progressive PACs helped boost her campaign in the final days of the primary.
"When there’s a real organizer running, we don’t need to match $ for $—we just need to be in the ring," Jayapal wrote on social media late Thursday.
Observers also marveled at AIPAC's blundering intervention in the race. UDP's ads against Malinowski did not mention Israel; rather, one of the spots condemned the former congressman for voting in 2019 to fund President Donald Trump's "deportation force," possibly pushing voters toward the candidate who has called for the abolition of Immigration and Customs Enforcement (ICE).
"ICE is not reformable nor fixable, and New Jerseyans know this," Mejia said last month. "We need members of Congress who are willing to stand up to authoritarianism and terror. The same old blue just won’t cut it."